What is Haemonetics's remainder of fiscal year 2024?

Haemonetics (HAE) reported remainder of fiscal year 2024 of $301.58M in Q4 2025.

How has Haemonetics's remainder of fiscal year 2024 changed year-over-year?

Haemonetics's remainder of fiscal year 2024 increased by 18784.0% year-over-year, from $1.6M to $301.58M.

Haemonetics HAE Remainder of Fiscal Year 2024

Remainder of Fiscal Year 2024 at other companies

AbbottABT

——

MedtronicMDT

——

ICU MedicalICUI

——

Bio-Rad LaboratoriesBIO

——

ITG

Integer HoldingsITGR

——

SolventumSOLV

——

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.31B-18.0%

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear.

The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's remainder of fiscal year 2024.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's remainder of fiscal year 2024?: Haemonetics (HAE) reported remainder of fiscal year 2024 of $301.58M in Q4 2025.
How has Haemonetics's remainder of fiscal year 2024 changed year-over-year?: Haemonetics's remainder of fiscal year 2024 increased by 18784.0% year-over-year, from $1.6M to $301.58M.